Myomo, Inc. (MYO) Gross Margin
- Gross margin · 12 months: Value 68.35%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 68.35% | Gross profit / revenue. Period ending 2026-06-30. $29.57M ÷ $43.26M × 100 ≈ 68.35% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 29.57M USD | Gross Profit |
| Revenue | 43.26M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 111.80K USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $29.57M | $43.26M | $111.80K | 68.35% |
| 2026-03-31 | $27.18M | $41.21M | $136.20K | 65.96% |
| 2025-12-31 | $26.89M | $40.93M | $109.00K | 65.70% |
| 2025-09-30 | $27.72M | $41.64M | $182.80K | 66.56% |
| 2025-06-30 | $28.22M | $40.76M | $164.40K | 69.24% |
| 2025-03-31 | $27.50M | $38.63M | $136.70K | 71.18% |
| 2024-12-31 | $23.19M | $32.55M | $216.40K | 71.23% |
| 2024-09-30 | $17.67M | $25.24M | (m) | 70.03% |
| 2024-06-30 | $14.22M | $21.11M | (m) | 67.35% |
| 2024-03-31 | $13.17M | $19.55M | (m) | 67.39% |
| 2023-12-31 | $13.18M | $19.24M | (m) | 68.51% |
| 2023-09-30 | $12.71M | $18.53M | (m) | 68.58% |
| 2023-06-30 | $11.86M | $17.41M | (m) | 68.12% |
| 2023-03-31 | $9.98M | $15.13M | (m) | 65.97% |
| 2022-12-31 | $10.25M | $15.56M | (m) | 65.91% |
| 2022-09-30 | $10.75M | $15.55M | (m) | 69.14% |
| 2022-08-16 | (m) | (m) | (m) | (m) |
| 2022-06-30 | $11.38M | $15.96M | (m) | 71.33% |
| 2022-03-31 | $11.18M | $15.39M | (m) | 72.64% |
| 2021-12-31 | $10.31M | $13.86M | $112.90K | 74.42% |
| 2021-09-30 | $9.97M | $13.61M | $214.90K | 73.25% |
| 2021-06-30 | $7.77M | $11.16M | $382.00K | 69.64% |
| 2021-03-31 | $6.01M | $8.91M | $466.60K | 67.40% |
| 2020-12-31 | $4.98M | $7.58M | $457.20K | 65.71% |
| 2020-09-30 | $3.80M | $5.31M | $507.50K | 71.50% |
| 2020-06-30 | $3.01M | $3.99M | $443.60K | 75.26% |
| 2020-03-31 | $3.07M | $4.02M | $484.00K | 76.36% |
| 2019-12-31 | $2.92M | $3.84M | $490.50K | 76.09% |
| 2019-09-30 | $2.36M | $3.21M | $471.20K | 73.57% |
| 2019-06-30 | $2.36M | $3.21M | $533.30K | 73.62% |
| 2019-03-31 | $2.16M | $2.96M | $513.30K | 73.10% |
| 2018-12-31 | $1.72M | $2.44M | $530.30K | 70.20% |
| 2018-09-30 | $1.40M | $2.10M | (m) | 66.41% |
| 2018-06-30 | $1.34M | $1.98M | (m) | 67.87% |
| 2018-03-31 | $1.12M | $1.66M | (m) | 67.70% |
| 2017-12-31 | $1.05M | $1.56M | (m) | 67.59% |
| 2017-09-30 | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | (m) |
| 2016-12-31 | $821.11K | $1.10M | (m) | 74.42% |
| 2016-09-30 | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| Bone Biologics Corp (BBLG) | United States | $0.001B |